BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9572042)

  • 1. Elevated serum levels of the soluble form of gp130, the IL-6 signal transducer, in HTLV-1 infection and no involvement of alternative splicing for its generation.
    Zhou Y; Horiuchi S; Yamamoto M; Yamamoto N
    Microbiol Immunol; 1998; 42(2):109-16. PubMed ID: 9572042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism.
    Horiuchi S; Koyanagi Y; Tanaka Y; Waki M; Matsumoto A; Zhou YW; Yamamoto M; Yamamoto N
    Immunology; 1997 May; 91(1):28-34. PubMed ID: 9203962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130.
    Diamant M; Rieneck K; Mechti N; Zhang XG; Svenson M; Bendtzen K; Klein B
    FEBS Lett; 1997 Jul; 412(2):379-84. PubMed ID: 9256256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism.
    Horiuchi S; Koyanagi Y; Zhou Y; Miyamoto H; Tanaka Y; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
    Eur J Immunol; 1994 Aug; 24(8):1945-8. PubMed ID: 8056053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD.
    Memoli B; Grandaliano G; Soccio M; Postiglione L; Guida B; Bisesti V; Esposito P; Procino A; Marrone D; Michael A; Andreucci M; Schena FP; Pertosa G
    J Am Soc Nephrol; 2005 Apr; 16(4):1099-107. PubMed ID: 15716332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble form of the interleukin-6 family signal transducer gp130 is dimerized via a C-terminal disulfide bridge resulting from alternative mRNA splicing.
    Wolf J; Waetzig GH; Reinheimer TM; Scheller J; Rose-John S; Garbers C
    Biochem Biophys Res Commun; 2016 Feb; 470(4):870-6. PubMed ID: 26809098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
    Sherwin JR; Smith SK; Wilson A; Sharkey AM
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
    Horiuchi S; Ampofo W; Koyanagi Y; Yamashita A; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
    Immunology; 1998 Nov; 95(3):360-9. PubMed ID: 9824498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans.
    Morozov VA; Lagaye S; Taylor GP; Matutes E; Weiss RA
    J Virol; 2000 May; 74(9):3933-40. PubMed ID: 10756004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction.
    Kinoshita T; Shimoyama M; Tobinai K; Ito M; Ito S; Ikeda S; Tajima K; Shimotohno K; Sugimura T
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5620-4. PubMed ID: 2787512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
    Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.
    Higashiyama Y; Katamine S; Kohno S; Mukae H; Hino S; Miyamoto T; Hara K
    Clin Exp Immunol; 1994 May; 96(2):193-201. PubMed ID: 7910532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia.
    Kinoshita T; Tsujimoto A; Shimotohno K
    Int J Cancer; 1991 Feb; 47(4):491-5. PubMed ID: 1995478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.
    Murata K; Hayashibara T; Sugahara K; Uemura A; Yamaguchi T; Harasawa H; Hasegawa H; Tsuruda K; Okazaki T; Koji T; Miyanishi T; Yamada Y; Kamihira S
    J Virol; 2006 Mar; 80(5):2495-505. PubMed ID: 16474156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.